Cancer incidence and prevalence in Isfahan: Application of mortality data to estimates and projects for the period 2001-2015

International Journal of Preventive Medicine

Volumn 3, Issue 12, 2012, Pages 867-874

  Maracy, Mohammad Reza ^a   Moradpour, Farhad ^b   Hosseini, Sayed Mohsen ^c   Tirani, Maryam ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; Incidence; Mortality; Prevalence; Relative survival

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ANALYTIC METHOD; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL COMPUTING; MORTALITY INCIDENCE ANALYSIS MODEL METHOD; PATIENT INFORMATION; PREVALENCE; PROBABILITY; RURAL AREA; SEX DIFFERENCE; SKIN CANCER; STANDARDIZATION; SURVIVAL RATE;

EID: 84871687316     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: 10.4103/2008-7802.104858     Document Type: Article

References (39)

1. ParkinDM. The evolution of the population-based cancer registry. Nat Rev Cancer 2006;6:603-12.
2. BrayF, MollerB. Predicting the future burden of cancer. Nat Rev Cancer 2006;6:63-74.
3. ThunMJ, DeLanceyJO, CenterMM, JemalA, WardEM. The global burden of cancer: Priorities for prevention. Carcinogenesis 2010;31:100-10.
4. MousaviSM, GouyaMM, RamazaniR, DavanlouM, HajsadeghiN, SeddighiZ. Cancer incidence and mortality in Iran. Ann Oncol 2009;20:556-63.
5. SadjadiA, NouraieM, MohagheghiMA, Mousavi-JarrahiA, MalekezadehR, ParkinDM. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 2005;6:359-63.
6. Sanchez MJ, Payer T, De Angelis R, Larranaga N, Capocaccia R, Martinez C. Cancer incidence and mortality in Spain: Estimates and projections for the period 1981-2012. Ann Oncol 2010;21:30-6.
7. GrandeE, InghelmannR, FrancisciS, VerdecchiaA, MicheliA, BailiP, et al. Regional estimates of all cancer malignancies in Italy. Tumori 2007;93:345-51.
8. GrandeE, InghelmannR, FrancisciS, VerdecchiaA, Micheli A, Capocaccia R, et al. Estimating regional cancer burden in countries with partial registration coverage: An application to all malignant neoplasms in Italy over the period 1970-2010. Eur J Cancer 2006;42:3236-45.
9. EtemadiA, SadjadiA, SemnaniS, NouraieSM, KhademiH, BahadoriM. Cancer registry in Iran: Abrief overview. Arch Iran Med 2008;11:577-80.
10. MokarianF, RamezaniMA, HeydariK, TabatabaeianM, TavazohiH. Epidemiology and trend of cancer in Isfahan 2005-2010. JRes Med Sci 2011;16:1228-33.
11. Ali MohagheghiM, Mosavi-JarrahiA. Review of cancer registration and cancer data in Iran, a historical prospect. Asian Pac J Cancer Prev 2010;11:1155-7.
12. KamoK, KanekoS, SatohK, YanagiharaH, MizunoS, SobueT. Amathematical estimation of true cancer incidence using data from population-based cancer registries. Jpn J Clin Oncol 2007;37:150-5.
13. VerdecchiaA, De AngelisR, FrancisciS, GrandeE. Methodology for estimation of cancer incidence, survival and prevalence in Italian regions. Tumori 2007;93:337-44.
14. De AngelisG, De AngelisR, FrovaL, VerdecchiaA. MIAMOD: Acomputer package to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed 1994;44:99-107.
15. VerdecchiaA, CapocacciaR, EgidiV, GoliniA. Amethod for the estimation of chronic disease morbidity and trends from mortality data. Stat Med 1989;8:201-16.
16. SantM, FrancisciS, CapocacciaR, VerdecchiaA, AllemaniC, BerrinoF. Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer 2006;119:2417-22.
17. VerdecchiaA, MariottoA, CapocacciaR, GattaG, Micheli A, Sant M, et al. Incidence and prevalence of all cancerous diseases in Italy: trends and implications. Eur J Cancer 2001;37:1149-57.
18. BernalM, RomeroFJ, SouzaDL, Gomez-BernalFJ, Gomez-Bernal GJ. Estimation of the projections of incidence rates, prevalence and mortality due to prostate cancer in Aragon(Spain). Actas Urol Esp 2011;35:470-4.
19. InghelmannR, GrandeE, FrancisciS, VerdecchiaA, MicheliA, BailiP, et al. Regional estimates of stomach cancer burden in Italy. Tumori 2007;93:367-73.
20. InghelmannR, GrandeE, FrancisciS, VerdecchiaA, MicheliA, BailiP, et al. Regional estimates of prostate cancer burden in Italy. Tumori 2007;93:380-6.
21. FritzA, PercyC, JachA, ShanmugaratnamK, SobinL, Parkin DM, et al., editors. 3rd ed. ICD-O: Internatinal Classification of Disease for Oncology; 2000.
22. Swaminathan R, Brenner H. Stastistical methods for cancer survival analysis. IARC Sci Publ 2011;132:7-13.
23. Karim-KosHE, de VriesE, SoerjomataramI, LemmensV, SieslingS, CoeberghJW. Recent trends of cancer in Europe: Acombined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44:1345-89.
24. JemalA, BrayF, CenterMM, FerlayJ, WardE, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
25. Iran SCo. Isfahan annual statistics 2008. 2009 Available from: http://www.amar.org.ir/esfahan/default-3188.aspx. [Last cited on 2011 Dec 04].
26. LopezAD, MathersCD, EzzatiM, JamisonDT, Murray CJ. Global Burden of Disease and Risk Factors. 1sted. Washington(DC): World Bank;2006.
27. BianchiniF, KaaksR, VainioH. Weight control and physical activity in cancer prevention. Obes Rev 2002;3:5-8.
28. CaseyMM, Thiede CallK, KlingnerJM. Are rural residents less likely to obtain recommended preventive healthcare services? Am J Prev Med 2001;21:182-8.
29. BryantH, MahZ. Breast cancer screening attitudes and behaviors of rural and urban women. Prev Med 1992;21:405-18.
30. WangF, McLaffertyS, EscamillaV, LuoL. Late-Stage Breast Cancer Diagnosis and Health Care Access in Illinois. Prof Geogr 2008;60:54-69.
31. CarrWP, MaldonadoG, LeonardPR, HalbergJU, Church TR, Mandel JH, et al. Mammogram utilization among farm women. JRural Health 1996;12:278-90.
32. National Cancer Registry Report 2003-2004. Tehran, Iran: Ministry of Health, Deputy for Health Directory, CDC Cancer Office; 2004.
33. National Cancer Registry Report 2004-2005. Tehran, Iran: Ministry of Health, Deputy for Health Directory, CDC Cancer Office; 2005.
34. National Cancer Registry Report 2005-2006. Tehran, Iran: Ministry of Health, Deputy for Health Directory, CDC Cancer Office; 2006.
35. National Cancer Registry Report 2006-2007. Tehran, Iran: Ministry of Health, Deputy for Health Directory, CDC Cancer Office; 2007.
36. National Cancer Registry Report 2007-2008. Tehran, Iran: Ministry of Health, Deputy for Health Directory, CDC Cancer Office; 2009. s
37. National Cancer Registry Report 2008-2009. Tehran, Iran: Ministry of Health, Deputy for Health Directory, CDC Cancer Office; 2010.
38. KaaksR, RinaldiS, KeyTJ, BerrinoF, PeetersPH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: The European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005;12:1071-82.
39. WingoPA, RiesLA, ParkerSL, HeathCW, Jr. Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev 1998;7:271-82.